Rise of AI ML-Powered Accelerators in Pharma Secure Supply Chain
AI in Pharmaceutical Manufacturing Operations
The Increasing Importance of Manufacturability in API Development
GLP 1 at Scale
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Generative AI in Drug Discovery: From Molecular Design to Translational Impact
Generative AI is changing how scientists think about drug discovery Rather than searching existing compound libraries or modifying known scaffolds these models can propose chemical ideas under defined constraints
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently
Thymidylate synthase TS is a key enzyme in thymidylate biosynthesis and an established target of chemotherapeutics such as fluorodeoxyuridine FdUR and raltitrexed RTX Inhibition of TS disrupts
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Emerging Biotechnologies: Navigating the Ethical Challenges Ahead
Sarah Richards
In this article, we propose an assessment of the different ethical aspects that stem from new biotechnological applications including gene editing, synthetic biology, and personalizing medicine. It lo...
-
2
FDA Regulatory Updates and Their Impact on Drug Approval Processes
Kate Williamson
This article will elaborate on the transformations of the restructured regulatory changes on the FDA drug approval processes, clinical development, compliance strategies, and accelerated pathways. It...
-
3
RNA Revolution: Advancing Drug Discovery through Targeted Molecules
Kate Williamson
The RNA revolution in drug discovery has introduced targeted molecules like ASOs, siRNA, and RNA vaccines, offering precise gene modulation and therapeutic versatility across genetic disorders, neurod...
-
4
How to Build a Metrics-Driven Culture in Pharma Quality Management
Kavita Vengurlekar
This article explores how pharma companies can build a metrics-driven quality culture that empowers teams and strengthens regulatory trust. It highlights critical QA metrics, real-world use cases, and...
-
5
Pharma Digital Magazines: High-Impact Content for Industry Leaders
Kate Williamson
Pharma digital magazines are changing the industry intelligence by providing high impact and data-driven intelligence to the executives and decision-makers. These B2B pharmaceutical magazines are a mi...
press releasesRead more...
Thermo Fisher Scientific Launches PPD™ CorEvitas™ Vitiligo Registry to Advance Real-World Evidence in Nonsegmental Vitiligo
Thermo Fisher Scientific the world leader in serving science today announced the launch of the PPD CorEvitas Vitiligo Registry a prospective observational clinical registry designed to generate longitudinal
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma
Allogene Therapeutics Inc Nasdaq ALLO a clinicalstage biotechnology company pioneering allogeneic CAR T AlloCAR T products for cancer and autoimmune disease today announced that the US
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
Johnson Johnson NYSE JNJ today announced the successful completion of its acquisition of Firefly Bio Inc a biotechnology company advancing its proprietary Firelink degrader antibody conjugate
Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T
Sail Biomedicines a Flagship Pioneering company creating a new class of RNA medicines today announced a strategic collaboration with Johnson Johnson to advance innovative In Vivo Chimeric Antigen Receptor Tcell
Events Read more...
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
28 - 30
Jul 20265th In Vivo Cell & Gene Summit 2026
500 Commonwealth Avenue, Bosto...
03 - 04
Aug 2026Clinical Pharmacology and Toxicology 2026
Dubai, UAE
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
LATEST NEWSRead more...
Octapharma to Invest US$1.5 Billion in First US Manufacturing Facility in South Carolina
Octapharma has announced plans to invest US billion in a new manufacturing and production facility at the Palmetto Research Park in Rock Hill South Carolina The project marks the companys first manufacturing site in the United States and is expected to create approximately full
TScan Therapeutics Doses First Patient in Phase 3 Trial of TSC-101 for Blood Cancers
TScan Therapeutics has dosed the first patient in its pivotal Phase ALLOHA trial evaluating TSC for the treatment of residual disease following allogeneic haematopoietic cell transplantation
Xencor to Receive US$105 Million From Alexion to Settle Ultomiris US Royalty Dispute
Xencor has reached an agreement with Alexion Pharma International Operations to resolve a commercial dispute over US royalties related to Ultomiris ravulizumabcwvz Under the settlement Xencor will receive US
DKSH Korea Expands Partnership with Novartis to Strengthen Hypertension Portfolio
DKSH Healthcare has expanded its strategic partnership with Novartis in South Korea by adding the hypertension medicines Diovan and Exforge to its prescription drug portfolio Under the agreement DKSH
Verastem Oncology Doses First Patient in Phase 2 Trial of VS-7375 for KRAS G12D-Mutated Metastatic Colorectal Cancer
Verastem Oncology has dosed the first patient in the TARGETD Phase registrationdirected clinical trial evaluating VS an investigational oral KRAS GD ONOFF inhibitor for the treatment of KRAS GDmutated metastatic colorectal cancer mCRC
IDEAYA Biosciences Begins Monotherapy Expansion of IDE892 Trial in MTAP-Deleted Pancreatic and Lung Cancers
IDEAYA Biosciences has initiated the Part monotherapy expansion of its Phase clinical trial evaluating IDE an investigational methylthioadenosine MTAcooperative PRMT inhibitor in patients with MTAPdeleted
